Ongoing

Treatment with CAN-3110 in arm A showed encouraging median…

Atos Provides an Update Regarding the ongoing Strategic…

<!-- Name:DistributionId Value:8780828 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

<!-- Name:DistributionId Value:8751468 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4573 -->…

<!-- Name:DistributionId Value:8750624 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4577 -->…

TETRANITE® is a novel biomaterial technology purpose-designed to reduce the duration and complexity of dental implant procedures LOWELL, Mass.--(BUSINESS WIRE)--#BoneAdhesive--RevBio, Inc. announced that it has received a strategic…

In January 2023, the 17th new patient was dosed with IMX-110 to datePositive safety data enabled continued dosing of previously enrolled patients Patients undergo CT scans every 8 weeks after dosing to assess tumor response to IMX-110;…

- Significant and rapid improvement in both signs and symptoms of TED after two infusions of 3 mg/kg, generally consistent with prior 10 and 20 mg/kg results – - Among 3 mg/kg VRDN-001 treated patients, 67% were proptosis responders, 56%…

LAS VEGAS, Jan. 5, 2023 /PRNewswire/ -- On January 4th, David Gold, President of Hisense USA, delivered a speech at Hisense CES 2023 Press Conference, sharing Hisense's international growth and successes in terms of its global layout,…

LOS ANGELES--(BUSINESS WIRE)--$DKNG #DKNG--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DraftKings Inc. (“DraftKings” or “the Company”) (NASDAQ:…